Allied Research Centers and Institutes
• The USC Norris Comprehensive Cancer Center (CCC), with nearly 200 members investigating the complex origins and progression of cancer, developing prevention strategies and searching for cures. USC Norris is part of the Keck School of Medicine and is designated by the National Cancer Institute as one of the nation’s 40 comprehensive cancer centers. Biomarkers for cancer will be crucial for targeted delivery. The USC/Norris Comprehensive Cancer Center is part of a new consortium of researchers embarking upon an intensive quest to pinpoint breast-cancer biomarkers—unique proteins in the blood that may signal the presence of cancer at its earliest stages, when survival rates from treatment are highest. More generally, the CCC clinical research focuses on testing new therapies for cancer, optimizing existing treatments, discovering prevention methods and developing ways to improve the quality of life for both healthy individuals and those living with cancer.
• The NIH funded Physical Sciences-Oncology Center (PS-OC) is creating a predictive model of cancer that can be used to determine tumor steady state growth and drug response, particularly those involved in the hematological malignancies of acute myeloid leukemia and non-Hodgkin lymphoma. Multi-scale physical measurements will be unified with sophisticated modeling approaches to model the tumor’s traits during its growth and after any distress, such as chemotherapeutic treatment. The PS-OC faculty also constitute a major component of an NCI Center for Cancer Nanotechnology Excellence focused on therapy response.
• The Biomimetic Microelectronic Systems Center (BMES) is a research center dedicated to the development of implantable microelectronic devices for the treatment of presently incurable diseases. Its strategy is to use microelectronic and biomedical technologies to create novel interventions for ophthalmic, neurological and other systemic disorders.
• The Biomedical Simulations Resource (BMSR) is dedicated to the advancement of the state-of-the-art in biomedical modeling and simulation through core and collaborative research projects, as well as the dissemination of this knowledge and related software .
• The Center for Biomedical Informatics Sciences (CBIS) combines biomedical informatics and biostatistical design to optimize service, training, and methodological developments in relation to study design, information management, and data analysis. CBIS supports research on cancer, molecular genetics, epigenetics, tumor micro environments, and clinical research on various cancers.
• The Whittier Nanobiotechnology Initiative is focused on accelerating research on both therapeutic and diagnostic uses of cutting-edge nanotechnologies to help eradicate serious diseases, including cancer, diabetes and cardiovascular.
• Alfred E. Mann Institute (AMI USC) for Biomedical Engineering bridges the gap between biomedical innovation and the creation of commercially-successful medical products to improve and save lives. AMI USC helps inventors mature their creations so that they can be transformed into commercially-viable medical products.
• The Southern California Clinical and Translational Science Institute (SC CTSI) promotes translation of scientific discoveries into new tools for clinical and community health. Created by the US National Institutes of Health (NIH), the SC CTSI is one of 60 research institutes nationwide that aim to speed research from laboratories to sustainable public health solutions. Our focus: improving the health of diverse populations in urban settings like Los Angeles.
• USC Stevens Center for Innovation is a university-wide resource for USC innovators in the office of the Provost. Designed to harness and advance the creative thinking and breakthrough research at USC, the USC Stevens Center was launched to develop a new model for interdisciplinary innovation.